Verisante Technology, Inc. (the "Company" or "Verisante"), a leader in cancer detection technology, announced today it has entered into an exclusive agreement with Frontière Médicale EUROPE LLC. ("Frontmed") to distribute Verisante Aura™ in the UK and Ireland.
[More]
Canon U.S.A., Inc., a leader in digital imaging solutions, is proud to announce a new location for the Healthcare Optics Research Laboratory in Cambridge, Massachusetts.
[More]
BIOLASE, Inc., the world's leading manufacturer and distributor of dental lasers, announced today that the U.S. Patent and Trademark Office has issued BIOLASE a new patent covering the use of its laser technologies for treating various conditions of the eye, including presbyopia, cataracts, and glaucoma.
[More]
OptiMedica Corp. has announced that it received a Red Herring 100 North America award, which honors the continent’s most promising private venture technology companies.
[More]
Although colonoscopy exams prevent many colon cancer deaths and are considered the most sensitive method for detecting colorectal cancers, the procedure is not completely effective in preventing cancer cases.
[More]
PENTAX Medical, a healthcare industry leader in endoscopic imaging, and Hitachi-Aloka Medical, a global leader in ultrasound imaging, recently announced renewed collaborative efforts between the two global companies to enable further innovation in the development of Endoscopic Ultrasound Systems (EUS).
[More]
BIOLASE, Inc., the world's leading manufacturer and distributor of dental lasers, announced today that the U.S. Food and Drug Administration (the "FDA") has cleared the NewTom™ BIOLASE VG3 ("VG3") digital panoramic, cephalometric, and tomographic extra-oral X-ray system which BIOLASE® will market and distribute in the U.S. for $50,000 to $120,000.
[More]
Research and Markets has announced the addition of the "Breast Imaging Technologies Market Analysis With Global Forecasts to 2017" report to their offering.
[More]
The Angiogenesis Foundation released a new white paper, "Advocating for Improved Treatment and Outcomes for Wet Age-Related Macular Degeneration" (AMD). Wet AMD is the most common form of blindness in people 50 years or older in developed nations.
[More]
A new stress test protocol that investigates reducing the use of perfusion imaging in low risk patients undergoing SPECT myocardial perfusion imaging for possible angina symptoms was found to be diagnostically safe, revealed a US retrospective analysis.
[More]